ES2183816T3 - Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion. - Google Patents

Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.

Info

Publication number
ES2183816T3
ES2183816T3 ES93919688T ES93919688T ES2183816T3 ES 2183816 T3 ES2183816 T3 ES 2183816T3 ES 93919688 T ES93919688 T ES 93919688T ES 93919688 T ES93919688 T ES 93919688T ES 2183816 T3 ES2183816 T3 ES 2183816T3
Authority
ES
Spain
Prior art keywords
injection
procedure
production
fabrics
altered tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93919688T
Other languages
English (en)
Inventor
Hideo Okazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Lequio Pharma Co Ltd
Original Assignee
Mitsubishi Pharma Corp
Lequio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp, Lequio Pharma Co Ltd filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ES2183816T3 publication Critical patent/ES2183816T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA INYECCION PARA CURAR TEJIDOS ANORMALES DAÑADOS QUE CONTIENE DE 0,01 A 0,5M DE UN COMPUESTO DE ALUMINIO SOLUBLE EN AGUA, DE UN 0,5 A UN 20%, EN BASE AL COMPUESTO DE ALUMINIO, DE ACIDO TANICO E HIDROGENSULFITO SODICO Y TIENE UN VALOR DE PH DE 1,5 A 3,5. LA INYECCION ES MUY ESTABLE INCLUSO CUANDO SE GUARDA DURANTE LARGOS PERIODOS DE TIEMPO, NO CAUSA NI DECOLORACION NI PRECIPITACION DURANTE EL ALMACENAMIENTO Y ES SIGNIFICATIVAMENTE EFICAZ PARA EL TRATAMIENTO DE TEJIDOS ANORMALES DAÑADOS, TALES COMO EL ANEURISMA CEREBRAL, LAS HEMORROIDES O HEPATOMAS, CUANDO SE INYECTA DIRECTAMENTE EN TALES TEJIDOS
ES93919688T 1992-09-18 1993-09-20 Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion. Expired - Lifetime ES2183816T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27513292 1992-09-18

Publications (1)

Publication Number Publication Date
ES2183816T3 true ES2183816T3 (es) 2003-04-01

Family

ID=17551146

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93919688T Expired - Lifetime ES2183816T3 (es) 1992-09-18 1993-09-20 Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.

Country Status (7)

Country Link
EP (1) EP0617964B1 (es)
AU (1) AU673005B2 (es)
CA (1) CA2129959C (es)
DE (1) DE69332219T2 (es)
ES (1) ES2183816T3 (es)
TW (1) TW274049B (es)
WO (1) WO1994006443A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750150A (en) * 1992-09-18 1998-05-12 Traditional Chinese Medicine Research Laboratory, Inc. Compositions for treating affected tissues, method for the preparation and usage thereof
DE69433055T2 (de) * 1993-11-17 2004-02-26 Lequio Pharma Co.Ltd., Naha Zusammensetzung zum heilen von verletztem gewebe, verfahren für ihre herstellung und ihre verwendung
US5773419A (en) * 1995-03-03 1998-06-30 Falcon; Juan Method of treating cancer with tannic acid
BR9811875A (pt) * 1997-08-08 2000-08-22 Atjje Inc Composição e processo de tratamento de câncer com ácido tânico e complexos de tanino
EP1300141B1 (en) * 2000-06-06 2008-03-19 Lequio Pharma Co., Ltd. Medical composition kit for treating lesioned abnormal tissue
US7252834B2 (en) 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
WO2011014563A1 (en) 2009-07-29 2011-02-03 Vatrix Medical, Inc. Tissue stabilization for heart failure
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
WO2012158944A1 (en) 2011-05-18 2012-11-22 Vatrix Medical, Inc. Coated balloons for blood vessel stabilization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56139423A (en) * 1980-04-02 1981-10-30 Toyo Seiyaku Kasei Kk Hemostatic agent for dental oral use
US4626433A (en) * 1985-05-20 1986-12-02 Preparation Gold, Inc. Remedy for hemorrhoids
DE3816442A1 (de) * 1988-05-13 1989-11-23 Tomic Dobrivoje Mittel zur behandlung mykotischer, mikrobischer und anderer gewebsschaedigender und pathologischer manifestationen und gewebsdeformationen
JP3133095B2 (ja) * 1990-04-25 2001-02-05 兆岐 史 消化器病変組織の硬化剤
AU653359B2 (en) * 1991-04-19 1994-09-29 Lequio Pharma Co. Ltd Hardening agent for affected tissues of the digestive system

Also Published As

Publication number Publication date
DE69332219D1 (de) 2002-09-26
EP0617964A4 (en) 1999-12-29
AU673005B2 (en) 1996-10-24
DE69332219T2 (de) 2003-01-09
AU4984493A (en) 1994-04-12
CA2129959A1 (en) 1994-03-03
CA2129959C (en) 2004-09-14
EP0617964B1 (en) 2002-08-21
EP0617964A1 (en) 1994-10-05
WO1994006443A1 (fr) 1994-03-31
TW274049B (es) 1996-04-11

Similar Documents

Publication Publication Date Title
FI875308A0 (fi) Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet.
PE12597A1 (es) Sales de quitosan con mejores propiedades absorbentes y proceso para su preparacion
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
ES2060775T3 (es) Egf para la prevencion de daños en tejidos despues de un episodio isquemico.
NO883127D0 (no) Heling av saar og regenerering av ben.
ES2183816T3 (es) Inyeccion para tratar tejidos alterados lesionados, procedimiento para su produccion, y su utilizacion.
ES416597A1 (es) Procedimiento de preparacion de albumina purificada.
SE8701662L (sv) Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
MX9100230A (es) Solucion de celulosa en agua y n-metilmorfolina-n-oxido
ES8307491A1 (es) Un metodo para preparar una composicion de gel acuoso semi- solido para alimentacion de heridos
ES2117426T3 (es) Forma cristalina de la sal anhidra compuesta de los acidos 7-((1a,5a,6a)-6-amino-3-azabiciclo(3.1.0.)hex-3-il)-6-fluoro-1-(2,4-difluorofenil)-1,4-dihidro-4-oxo-1,8-naftiridina-3-carboxilico y metanosulfonico.
SV1994000076A (es) Derivados de acido n-acetil neuraminico cristalino y su preparacion ref. 1123a/sv
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
ATE27269T1 (de) Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung.
AR247804A1 (es) Composicion biocida sinergica y metodo para proteger con la misma composiciones industriales
JPS567716A (en) Preventive and remedy for cerebral angiospasm
ES8708220A1 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
NO933114L (no) Fremstilling av faktor ix
ATE59554T1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
ES2109530T3 (es) Derivados de acidos fenil-ciclohexano-carboxilicos heterotriciclicamente sustituidos.
EP0142597A3 (en) Curative composition for buerger's disease
ES551363A0 (es) Procedimiento para fabricar carbonato de sodio anhidro denso
GR77250B (es)
DE3065387D1 (en) Purification of l-aspartyl-l-phenylalanine alkyl esters
DE58903397D1 (de) Derivate der 2-pyrrolidon-5-carbonsaeure und verfahren zu ihrer gewinnung.